Parvin Zamani

Shahid Sadoughi University of Medical Sciences and Health Services — IR

Biochemistry, Genetics and Molecular Biology · Life Sciences

22h-index1.6kcitations49works7.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

RNA Interference and Gene Delivery(14), Immunotherapy and Immune Responses(13), Nanoparticle-Based Drug Delivery(10), Advanced biosensing and bioanalysis techniques(6), Nanoplatforms for cancer theranostics(5)

Publications49 total

Combination therapy with VEGFR2 nanoliposomal peptide and paclitaxel in murine models of melanoma: a promising strategy for enhancing the efficacy of cancer immunotherapy
International Immunopharmacology·2025
Resilience and Transformation of University Waste Management During COVID-19: A Case Study of Shahid Sadoughi University of Medical Sciences, Yazd
Journal of Environmental Health and Sustainable Development·2025Open Access
Harnessing CRISPR technology for viral therapeutics and vaccines: from preclinical studies to clinical applications
Virus Research·2024· 22 citedOpen Access
Novel liposomal glatiramer acetate: Preparation and immunomodulatory evaluation in murine model of multiple sclerosis
International Journal of Pharmaceutics·2023· 9 cited
Improving the efficacy of peptide vaccines in cancer immunotherapy
International Immunopharmacology·2023· 21 cited
The effect of m2 peptide targeted nanoliposomes containing crocin on induction of phenotypic change in tumor macrophages to M1 state
Life Sciences·2023· 6 cited
Characterization of stability, safety and immunogenicity of the mRNA lipid nanoparticle vaccine Iribovax® against COVID-19 in nonhuman primates
Journal of Controlled Release·2023· 25 cited
Nanoliposomal VEGF-R2 peptide vaccine acts as an effective therapeutic vaccine in a murine B16F10 model of melanoma
Cancer Nanotechnology·2023· 13 citedOpen Access
Preparation of AS1411 aptamer-modified PEGylated liposomal doxorubicin and evaluation of its anti-cancer effects in vitro and in vivo
Journal of Drug Delivery Science and Technology·2023· 14 cited
A novel formulation of cyclosporine A/phosphatidylserine-containing liposome using remote loading method: Potential product for immunosuppressive effects
Journal of Drug Delivery Science and Technology·2022· 8 cited
Improving potency of Nanoliposomal AE36 peptide vaccine by adding CD4+ T cell helper epitope and MPL in TUBO breast cancer mice model
Journal of Drug Delivery Science and Technology·2022· 8 cited
An insight into the role of liposomal therapeutics in the reversion of multiple sclerosis
Expert Opinion on Drug Delivery·2021· 6 cited
Overweight and Obesity are Potential Risk Factors for Disrupted Nocturnal Sleep in Iranian Adults: A Cross-Sectional Study
International Journal of Public Health·2021· 5 citedOpen Access
Vaccines targeting angiogenesis in melanoma
European Journal of Pharmacology·2021· 12 cited
Multi-antigen vaccination with LPD nanoparticles containing rgp63 and rLmaC1N proteins induced effective immune response against leishmaniasis in animal model
Journal of Drug Delivery Science and Technology·2021· 4 cited
Liposomal doxorubicin targeting mitochondria: A novel formulation to enhance anti-tumor effects of Doxil® in vitro and in vivo
Journal of Drug Delivery Science and Technology·2021· 21 cited
<scp>Anti‐</scp> epithelial cell adhesion molecule <scp>RNA</scp> aptamer‐conjugated liposomal doxorubicin as an efficient targeted therapy in mice bearing colon carcinoma tumor model
Biotechnology Progress·2020· 26 cited
Recent Advancements in Liposome-Based Strategies for Effective Drug Delivery to the Brain
Current Medicinal Chemistry·2020· 15 cited
Author response for "&lt;scp&gt;Anti‐EpCAM RNA&lt;/scp&gt; aptamer‐conjugated liposomal doxorubicin as an efficient targeted therapy in mice bearing colon carcinoma tumor model"
2020Open Access
Immunoliposomes bearing lymphocyte activation gene 3 fusion protein and <scp>P5</scp> peptide: A novel vaccine for breast cancer
Biotechnology Progress·2020· 21 cited
page 1 of 3Next →

Frequent Co-authors

Mahmoud Reza Jaafari(27), Mohammad Mashreghi(13), Amirhossein Sahebkar(8), Jamshid Gholizadeh Navashenaq(7), Gordon A. Ferns(7), Maryam Tayefi(6), Amin Reza Nikpoor(6), Ali Badiee(6), Majid Ghayour‐Mobarhan(6), Fatemeh Zahedipour(6), Narges Fereydouni(5), Susan Darroudi(5), Habibollah Esmaily(5), Khadijeh Jamialahmadi(5), Reza Kazemi Oskuee(4), Seyedeh Alia Moosavian(4), Maryam Karimi(4), Javad Zarqi(4), Seyedeh Hoda Alavizadeh(4), Amir Abbas Momtazi‐Borojeni(3)